Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

Author： Yang Meng   Liu Yun-Duo   Wang Yan-Ying   Liu Tian-Bo   Ge Ting-Ting   Lou Ge  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.35, Iss.2, 2014-02, pp. : 929-934

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ubiquitinspecific protease 22induced autophagy is correlated with poor prognosis of pancreatic cancer

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2726-2734

Spandidos Publications

Access to resources Recommend Favorite

Ubiquitin-specific proteases as cancer drug targets

By Sippl Wolfgang   Collura Vincent   Colland Fréédééric  

Future Oncology, Vol. 7, Iss. 5, 2011-05 ,pp. : 619-632

Future Medicine

Access to resources Recommend Favorite

Ubiquitin-specific peptidase 22 inhibits colon cancer cell invasion by suppressing the signal transducer and activator of transcription 3/matrix metalloproteinase 9 pathway

By          

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 2107-2113

Spandidos Publications

Access to resources Recommend Favorite

Ubiquitin specific protease 22 promotes cell proliferation and tumor growth of epithelial ovarian cancer through synergy with transforming growth factor β1

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 133-140

Spandidos Publications

Access to resources Recommend Favorite

Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cells

By                

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 268-272

Spandidos Publications

Access to resources Recommend Favorite